Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Valeant Pharmaceuticals International Inc (NYSE:VRX)

30.84
BATS BZX Real-Time Price
As of 2:23pm ET
 -0.365 / -1.17%
Today’s Change
18.55
Today|||52-Week Range
245.82
-69.67%
Year-to-Date
4 Big-Name Investment Funds That Strongly Believe in a Valeant Pharmaceuticals Turnar...
Aug 23 / MotleyFool.com - Paid Partner Content
Valeant Pharmaceuticals (VRX) Appoints New CFO, Stock Gains 7.2%
Aug 22 / Zacks.com - Paid Partner Content
Stock Market News for August 23, 2016
Aug 23 / Zacks.com - Paid Partner Content
Jim Cramer -- Valeant Investors Should Welcome a High-Quality CFO
Aug 22 / TheStreet.com - Paid Partner Content
Why Syngenta, Valeant Pharmaceuticals, and BioMarin Pharmaceutical Jumped Today
Aug 22 / MotleyFool.com - Paid Partner Content
Allergan Makes an Eye-Opening Acquisition
Aug 22 / MotleyFool.com - Paid Partner Content
Stocks Waver as Investors Wait for Fed Clarity
Aug 22 / TheStreet.com - Paid Partner Content
Morning Movers: PFE, VRX, VIAB, FL, UA
Aug 22 / TheStreet.com - Paid Partner Content
Valeant's C-Suite Sees Another Shake-Up
Aug 22 / TheStreet.com - Paid Partner Content
Valeant (VRX) Stock Climbs, Hires Zoetis' Herendeen as CFO
Aug 22 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close31.20
Today’s open31.35
Day’s range30.71 - 32.74
Volume1,669,999
Average volume (3 months)30,469,733
Market cap$10.6B
Dividend yield--
Data as of 2:23pm ET, 08/24/2016

Growth & Valuation

Earnings growth (last year)-131.25%
Earnings growth (this year)-35.41%
Earnings growth (next 5 years)+10.35%
Revenue growth (last year)+26.42%
P/E ratioNM
Price/Sales3.32
Price/Book1.81

Competitors

 Today’s
change
Today’s
% change
MNKMallinckrodt Plc-0.56-0.67%
PRGOPerrigo Company PLC-2.78-3.04%
JAZZJazz Pharmaceuticals...-3.07-2.28%
MDVNMedivation Inc0.000.00%
Data as of 2:23pm ET, 08/24/2016

Financials

Next reporting dateOctober 17, 2016
EPS forecast (this quarter)$1.79
Annual revenue (last year)$10.4B
Annual profit (last year)-$291.7M
Net profit margin-2.79%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Joseph C. Papa
Chief Financial Officer &
Executive VP-Finance
Paul S. Herendeen
Corporate headquarters
Laval, Qubec

Forecasts

Partner Offers

Search for Jobs